CL2004000948A1 - SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY - Google Patents

SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY

Info

Publication number
CL2004000948A1
CL2004000948A1 CL200400948A CL2004000948A CL2004000948A1 CL 2004000948 A1 CL2004000948 A1 CL 2004000948A1 CL 200400948 A CL200400948 A CL 200400948A CL 2004000948 A CL2004000948 A CL 2004000948A CL 2004000948 A1 CL2004000948 A1 CL 2004000948A1
Authority
CL
Chile
Prior art keywords
anorexy
anxiety
understands
depression
treatment
Prior art date
Application number
CL200400948A
Other languages
Spanish (es)
Inventor
Ramachandra Rao Raje Dharmaraj
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of CL2004000948A1 publication Critical patent/CL2004000948A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
CL200400948A 2003-05-06 2004-05-04 SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY CL2004000948A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310361.1A GB0310361D0 (en) 2003-05-06 2003-05-06 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
CL2004000948A1 true CL2004000948A1 (en) 2005-04-22

Family

ID=9957512

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400948A CL2004000948A1 (en) 2003-05-06 2004-05-04 SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY

Country Status (7)

Country Link
EP (1) EP1620388A1 (en)
KR (1) KR20060034636A (en)
AR (1) AR046070A1 (en)
CL (1) CL2004000948A1 (en)
GB (1) GB0310361D0 (en)
PA (1) PA8602001A1 (en)
WO (1) WO2004099119A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432398B2 (en) * 2005-01-06 2008-10-07 Cj Corporation Inorganic acid salts of sibutramine
KR100814384B1 (en) * 2006-02-10 2008-03-18 대화제약 주식회사 Pharmaceutical composition containing sibutramine salt, and manufacturing method thereof
KR100806673B1 (en) * 2006-06-23 2008-03-03 주식회사 대희화학 Process for Preparing Crystalline Sibutramine Free Base

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound

Also Published As

Publication number Publication date
EP1620388A1 (en) 2006-02-01
GB0310361D0 (en) 2003-06-11
AR046070A1 (en) 2005-11-23
WO2004099119A1 (en) 2004-11-18
PA8602001A1 (en) 2004-11-26
KR20060034636A (en) 2006-04-24

Similar Documents

Publication Publication Date Title
BRPI0719497A2 (en) "COMPOSITION, PROCESS OF PREPARING A COMPOSITION, USES OF A COMPOSITION, AND COMETIC USE OF A COMPOSITION"
BRPI0717695A2 (en) "composition, use of a composition and process of preparing a composition"
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
IS8669A (en) Rasagiline formulations in which the homogeneity of the ingredients has been improved
EP1895580A4 (en) Adhesive composition for semiconductor, semiconductor device making use of the same and process for producing semiconductor device
MXPA03001789A (en) COMPOSITIONS FOR CARE OF FABRICS THAT INCLUDE CATIONIC SILICONES AND METHODS THAT USE THE SAME.
CR8226A (en) PROCESS FOR THE PREPARATION OF 4-AMINO-3-QUINOLINCARBONITRILOS
BRPI0815457A2 (en) "POLYTRYMETHYLENE TEREPHALATE BASED COMPOSITION, PROCESS FOR PREPARING POLYMRYMETHYLENE TEREPHALATE BASIS AND ARTICLE"
DK1480615T3 (en) Super fine formoterol formulation
FR2885035B1 (en) COMPRESSIVE ORTHESIS OF THE LOWER LIMIT OF LOW TYPE TRICOTE ARTICLE, SOCK OR TIGHTS
AT8676U9 (en) COPY-MILLING DEVICE FOR PRODUCING, IN PARTICULAR, DENTAL WORKPIECES
DE102005001078A8 (en) Glass powder, in particular biologically active glass powder and process for the production of glass powder, in particular biologically active glass powder
CL2004000306A1 (en) COMPOUNDS DERIVED FROM PYRIMIDINE REPLACED WITH INDANO; PROCESS FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; PHARMACEUTICAL COMBINATION; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF AN INFECTIOUS DISEASE.
BRPI0717699A2 (en) "COMPOSITION AND ITS PROCESSES FOR PREPARATION, USE OF A COMPOSITION, AND COMESTIC USE OF A COMPOSITION!
DK1467724T3 (en) Pharmaceutical composition with agomelatine for dispersal in the oral cavity
DE602004031510D1 (en) SILICONE RESIN COMPOSITION AND FORM BODY THEREOF
BRPI0807271A2 (en) 'USE OF A COMPOSITION, FORMULATIONS IN THE MELTED STATE AND PROCESS FOR MANUFACTURING A MICROCELLULAR POLYAMIDE ARTICLE'
CL2004000948A1 (en) SIBUTRAMINE FREE BASE IN CRYSTALLINE FORM CHARACTERIZED BY ITS X-RAY DIFRACTOGRAM; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; AND USE IN THE TREATMENT OF DEPRESSION, ANOREXY, DISORDERS CONCERNED WITH ANXIETY
PL1874733T3 (en) Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
ECSP109874A (en) NEW COMPOUNDS 892
HK1093906A1 (en) Use of agomelatine in obtaining medicaments intended for the treatmemt of bipolar disorders
ITMI20041941A1 (en) PROCESS FOR THE PREPARATION OF LYSOPOSPHATIDYLCHOLINE
DE60336417D1 (en) LIQUID COMPOSITIONS WITH 3,7-DIAZABICYCLOE3,3,1,1-NONANESE FOR THE TREATMENT OF ANTI-ARRHYTHMIC EVENTS
ITRE20040074A1 (en) "FRAGRANCE FOR ENVIRONMENTS"
ATA10862001A (en) POSTER, ESPECIALLY FOR APPLICATION TO MASTS AND THE LIKE